financial instruments of Baht 1,328 million consists of gains on securities of Baht 144 million, gains on derivatives of Baht 911 million, and interest and dividend income of Baht 273 million. Expenses The

. Gross profit margin was higher from 27.2 to 31.2% due to focusing on higher-margin sales. Total expenses were Baht 458.3 million, decreased by 9.2%. The temporary shutdown expenses for scheduled

7.40 Other income 2,187 1,266 921 72.75 Profit before expense 55,142 50,572 4,570 9.04 Selling and distribution expenses (44,345) (30,778) 13,567 (44.08) Administrative expenses (54,765) (52,733) 2,032

in debt and equity securities for the Company’s own account, bond dealing, private repos and other investments. 2. Expenses The Company’s expenses in the third quarter of 2020 were Baht 482 million, a

pay and doctor fee. Selling Expenses The selling expenses for Year 2017 and 2018 were in amounts of Baht 15.03 million and Baht 15.83 million, inclining by 5.4%. The proportion of selling expenses

profit 278.32 434.06 55.96% Selling expenses (70.95) (75.20) 5.99% Administrative expenses (144.64) (125.35) -13.34% Operating profit 62.73 233.51 272.25% Investment income 0.23 0.50 117.39% Net foreign

reason of increasing in gain from exchange rate. 1.2 Cost of goods sold and expenses Consolidated financial statements (Thousands Baht) Nine-month Change 3nd Quarter Change 2562 2561 Amount % 2562 2561

from fully operational of Wattanapat Ao Nang hospital (fully operational in March 2019), such as employee expenses, doctor fee, cost of goods sold, depreciation infrastructures and so forth. Selling

subsidiaries registered consolidated rental and service income of a decrease by 10.02% or equivalent to Baht 2.23 million where other income decreased 13.93% or equivalent to Baht 3.44 million. 2 Expenses Cost

last year for a reason of increasing in gain from exchange rate. 1.2 Cost of goods sold and expenses Consolidated financial statements (Thousands Baht) Six-month Change 2nd Quarter Change 2562 2561